title: Hospital admissions following outpatient administration of high-dose melphalan and autologous SCT for AL amyloidosis.
authors: Stem Cell Transplantation Program, Section of Hematology/Oncology, Boston Medical Center, Boston, MA, USA.
authors: B
authors: B
authors: Freeman
authors: Stem Cell Transplantation Program, Section of Hematology/Oncology, Boston Medical Center, Boston, MA, USA.
authors: D
authors: D
authors: Brauneis
authors: Stem Cell Transplantation Program, Section of Hematology/Oncology, Boston Medical Center, Boston, MA, USA.
authors: D C
authors: DC
authors: Seldin
authors: Stem Cell Transplantation Program, Section of Hematology/Oncology, Boston Medical Center, Boston, MA, USA.
authors: K
authors: K
authors: Quillen
authors: Stem Cell Transplantation Program, Section of Hematology/Oncology, Boston Medical Center, Boston, MA, USA.
authors: J M
authors: JM
authors: Sloan
authors: Stem Cell Transplantation Program, Section of Hematology/Oncology, Boston Medical Center, Boston, MA, USA.
authors: A S
authors: AS
authors: Renteria
authors: Stem Cell Transplantation Program, Section of Hematology/Oncology, Boston Medical Center, Boston, MA, USA.
authors: A C
authors: AC
authors: Shelton
authors: Stem Cell Transplantation Program, Section of Hematology/Oncology, Boston Medical Center, Boston, MA, USA.
authors: T
authors: T
authors: Teschner
authors: Stem Cell Transplantation Program, Section of Hematology/Oncology, Boston Medical Center, Boston, MA, USA.
authors: K T
authors: KT
authors: Finn
authors: Stem Cell Transplantation Program, Section of Hematology/Oncology, Boston Medical Center, Boston, MA, USA.
authors: V
authors: V
authors: Sanchorawala
mesh_terms: D000686:Amyloidosis / Q000188:drug therapy*; D018906:Antineoplastic Agents, Alkylating / Q000008:administration & dosage / Q000627:therapeutic use*; D018380:Hematopoietic Stem Cell Transplantation / Q000379:methods*; D006760:Hospitalization / Q000639:trends*; D006801:Humans; D000075363:Immunoglobulin Light-chain Amyloidosis; D008558:Melphalan / Q000008:administration & dosage / Q000627:therapeutic use*; D012189:Retrospective Studies; D019172:Transplantation Conditioning / Q000379:methods*
chemical_list: D018906:Antineoplastic Agents, Alkylating; D008558:Melphalan